PolyPeptide Group AG (SWX:PPGN)
Switzerland
· Delayed Price · Currency is CHF 28.05
+1.90 (7.27%)
Aug 14, 2025, 4:45 PM CET
PolyPeptide Group AG Revenue
PolyPeptide Group AG had revenue of 167.10M EUR in the half year ending June 30, 2025, with 26.75% growth. This brings the company's revenue in the last twelve months to 368.85M, up 13.99% year-over-year. In the year 2024, PolyPeptide Group AG had annual revenue of 336.79M with 5.13% growth.
Revenue (ttm)
368.85M EUR
Revenue Growth
+13.99%
P/S Ratio
2.50
Revenue / Employee
270.81K EUR
Employees
1,362
Market Cap
862.73M CHF
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.49B |
| Novartis AG | 43.89B |
| Lonza Group AG | 7.09B |
| Alcon | 8.77B |
| Galderma Group AG | 3.73B |
| Sandoz Group AG | 9.41B |
| Straumann Holding AG | 2.50B |
| Sonova Holding AG | 3.87B |